EX-23

                                                      2












             Report of Independent Registered Public Accounting Firm



The Board of Directors and Shareholders of
Oppenheimer Series Fund, Inc.:


In planning and performing our audit of the financial statements of Oppenheimer
Value Fund (a portfolio of the Oppenheimer Series Fund, Inc.) as of and for the
year ended October 31, 2009, in accordance with the standards of the Public
Company Accounting Oversight Board (United States), we considered the Fund's
internal control over financial reporting, including controls over safeguarding
securities, as a basis for designing our auditing procedures for the purpose of
expressing our opinion on the financial statements and to comply with the
requirements of Form N-SAR, but not for the purpose of expressing an opinion on
the effectiveness of the Fund's internal control over financial reporting.
Accordingly, we express no such opinion.

Management of the Fund is responsible for establishing and maintaining effective
internal control over financial reporting. In fulfilling this responsibility,
estimates and judgments by management are required to assess the expected
benefits and related costs of controls. A company's internal control over
financial reporting is a process designed to provide reasonable assurance
regarding the reliability of financial reporting and the preparation of
financial statements for external purposes in accordance with generally accepted
accounting principles. A company's internal control over financial reporting
includes those policies and procedures that (1) pertain to the maintenance of
records that, in reasonable detail, accurately and fairly reflect the
transactions and dispositions of the assets of the company; (2) provide
reasonable assurance that transactions are recorded as necessary to permit
preparation of financial statements in accordance with generally accepted
accounting principles, and that receipts and expenditures of the company are
being made only in accordance with authorizations of management and directors of
the company; and (3) provide reasonable assurance regarding prevention or timely
detection of unauthorized acquisition, use, or disposition of the company's
assets that could have a material effect on the financial statements.

Because of its inherent limitations, internal control over financial reporting
may not prevent or detect misstatements. Also, projections of any evaluation of
effectiveness to future periods are subject to the risk that controls may become
inadequate because of changes in conditions, or that the degree of compliance
with the policies or procedures may deteriorate.

A deficiency in internal control over financial reporting exists when the design
or operation of a control does not allow management or employees, in the normal
course of performing their assigned functions, to prevent or detect
misstatements on a timely basis. A material weakness is a deficiency, or a
combination of deficiencies, in internal control over financial reporting, such
that there is a reasonable possibility that a material misstatement of the
Fund's annual or interim financial statements will not be prevented or detected
on a timely basis.

Our consideration of the Fund's internal control over financial reporting was
for the limited purpose described in the first paragraph and would not
necessarily disclose all deficiencies in internal control that might be material
weaknesses under standards established by the Public Company Accounting
Oversight Board (United States). However, we noted no deficiencies in the Fund's
internal control over financial reporting and its operation, including controls
over safeguarding securities, that we consider to be a material weakness as
defined above as of October 31, 2009.

This report is intended solely for the information and use of management and the
Board of Directors of the Oppenheimer Series Fund, Inc. and the Securities and
Exchange Commission, and is not intended to be and should not be used by anyone
other than these specified parties.





                                    KPMG LLP



Denver, Colorado
December 16, 2009

EX-99.77E LEGAL

                                N-SAR EXHIBIT 77E


Pending Litigation. During 2009, a number of lawsuits have been filed in federal
courts against the Manager, the Distributor, and certain funds in the
Oppenheimer family of funds (the "Defendant Funds") advised by the Manager and
distributed by the Distributor (but not against the Fund). The lawsuits naming
the Defendant Funds also name certain officers, trustees and former trustees of
the respective Defendant Funds. The plaintiffs seek class action status on
behalf of purchasers of shares of the respective Defendant Fund during a
particular time period. The lawsuits against the Defendant Funds raise claims
under federal securities laws alleging that, among other things, the disclosure
documents of the respective Defendant Fund contained misrepresentations and
omissions, that such Defendant Fund's investment policies were not followed, and
that such Defendant Fund and the other defendants violated federal securities
laws and regulations. The plaintiffs seek unspecified damages, equitable relief
and an award of attorneys' fees and litigation expenses. Additionally, a lawsuit
has been brought in state court against the Manager, the Distributor and another
subsidiary of the Manager (but not the Fund), on behalf of the Oregon College
Savings Plan Trust, and other lawsuits have been brought in state court against
the Manager and that subsidiary (but not against the Fund), on behalf of the New
Mexico Education Plan Trust. An agreement in principal has been reached to
settle the lawsuit on behalf of the Oregon Savings Plan Trust. All of these
lawsuits allege breach of contract, breach of fiduciary duty, negligence and
violation of state securities laws, and seek compensatory damages, equitable
relief and an award of attorneys' fees and litigation expenses.

         Other lawsuits have been filed in 2008 and 2009 in state and federal
courts, by investors who made investments through an affiliate of the Manager,
against the Manager and certain of its affiliates. Those lawsuits relate to the
alleged investment fraud perpetrated by Bernard Madoff and his firm ("Madoff")
and allege a variety of claims including breach of fiduciary duty, fraud,
negligent misrepresentation, unjust enrichment, and violation of federal and
state securities laws and regulations, among others. They seek unspecified
damages, equitable relief, and an award of attorneys' fees and litigation
expenses. None of the suits have named the Distributor, any of the Oppenheimer
mutual funds or any of their independent Trustees or Directors. None of the
Oppenheimer funds invested in any funds or accounts managed by Madoff.

         The Manager believes that the lawsuits described above are without
legal merit and intends to defend them vigorously. The Defendant Funds' Boards
of Trustees have also engaged counsel to defend the suits vigorously on behalf
of those Funds, their boards and the Trustees named in those suits. The Manager
believes that it is premature to render any opinion as to the likelihood of an
outcome unfavorable to it and that no estimate can be made with any degree of
certainty as to the amount or range of any potential loss. The Manager also
believes that these suits should not impair the ability of the Manager or the
Distributor to perform their respective duties to the Fund.

EX-99

Net investment income (loss) and net realized gain (loss) may differ for
financial statement and tax purposes. The character of dividends and
distributions made during the fiscal year from net investment income or net
realized gains may differ from their ultimate characterization for federal
income tax purposes. Also, due to timing of dividends and distributions, the
fiscal year in which amounts are distributed may differ from the fiscal year in
which the income or net realized gain was recorded by the Fund.
Accordingly, the following amounts have been reclassified for October 31, 2009.
Net assets of the Fund were unaffected by the reclassifications.


                                                Reduction to        Increase to
                                                 Accumulated    Accumulated Net
                           Increase to        Net Investment      Realized Loss
                       Paid-in Capital                Income     on Investments
                      ---------------------------------------------------------
                            $1,420,352            $1,167,101           $253,251

EX-99.77Q1 OTHR EXHB

EXHIBIT 77Q1

                          OPPENHEIMER SERIES FUND, INC.
                             ARTICLES SUPPLEMENTARY

         Oppenheimer Series Fund, Inc., a Maryland corporation, having its
 principal office in Baltimore City, Maryland (hereinafter called the
"Corporation"), hereby certifies to the State Department of Assessments and
Taxation of Maryland that:

         FIRST: The Corporation is registered as an open-end company under the
Investment Company Act of 1940, as amended, with the authority to issue
3,000,000,000 (Three Billion) shares of capital stock, par value $0.001 per
share and aggregate par value $3,000,000, initially classified as Common Stock
and further classified as follows:

         Series and Classes                            Authorized Shares

         Oppenheimer Value Fund
              Class A Common Stock                       300,000,000
              Class B Common Stock                       100,000,000
              Class C Common Stock                       50,000,000
              Class N Common Stock                       100,000,000
              Class Y Common Stock                       100,000,000

The remaining 2,350,000,000 shares of Common Stock of the Corporation are
undesignated as to series or class.

         SECOND: The Board of Directors hereby reclassifies as Class Y shares of
Oppenheimer Value Fund 50,000,000 shares of Common Stock that were previously
undesignated as to series or class.

         THIRD: After this reclassification, the total number of shares of all
classes and series of stock which the Corporation has authority to issue remains
3,000,000,000 (Three Billion) shares of capital stock, par value $0.001 per
share and aggregate par value $3,000,000, and is, classified and designated as
follows.

         Series and Classes                              Authorized Shares

         Oppenheimer Value Fund
              Class A Common Stock                         300,000,000
              Class B Common Stock                         100,000,000
              Class C Common Stock                         50,000,000
              Class N Common Stock                         100,000,000
              Class Y Common Stock                         150,000,000

The remaining 2,300,000,000 shares of Common Stock of the Corporation are
undesignated as to series or class.

         FOURTH: The forgoing does not change the preferences, conversion or
other rights, voting powers, restrictions, limitations as to dividends,
qualifications, or terms or conditions of redemption, as set forth in the
Charter, of the capital stock of the Corporation existing before the
reclassification. The terms of the reclassified Class Y shares of the
Oppenheimer Value Fund (including the preferences, conversion or other rights,
voting powers, restrictions, limitations as to dividends and other
distributions, qualifications, or terms or conditions of redemption) shall be as
set forth in the Charter for the capital stock of the Corporation existing
before the reclassification.

         FIFTH: The foregoing reclassification has been approved by a majority
of the entire Board of Directors pursuant to authority expressly granted to the
Board of Directors by Sections 2-105(a)(9), and 2-605(a)(2) of the Maryland
General Corporation Law, and in Article IV of the Charter of the Corporation.

         SIXTH: The foregoing articles shall become effective upon filing with
the State Department of Assessments and Taxation of Maryland.

IN WITNESS WHEREOF, OPPENHEIMER SERIES FUND, INC., has caused these presents to
be signed in its name and on its behalf by its Vice President and witnessed by
its Assistant Secretary on May 15, 2009.

WITNESS:                                     OPPENHEIMER SERIES FUND, INC.

/s/ Taylor V. Edwards                            By: /s/ Mark Vandehey
- -------------------------------------- ----------------------------------------
Taylor V. Edwards, Assistant Secretary       Mark Vandehey, Vice President

         THE UNDERSIGNED, Vice President of OPPENHEIMER SERIES FUND, INC., who
executed on behalf of the Corporation the foregoing Articles Supplementary of
which this certificate is made a part, hereby acknowledges in the name and on
behalf of said Corporation the foregoing Articles Supplementary to be the
corporate act of said Corporation and hereby certifies that to the best of his
knowledge, information, and belief the matters and facts set forth therein with
respect to the authorization and approval thereof are true in all material
respects under the penalties of perjury.

                                    /s/ Mark Vandehey
                                    Mark Vandehey, Vice President